Aratana Therapeutics, Inc. EBITDA 2013-2019 | PETX
Aratana Therapeutics, Inc. ebitda from 2013 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Aratana Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-11 |
| 2017 | $-43 |
| 2016 | $-30 |
| 2015 | $-88 |
| 2014 | $-40 |
| 2013 | $-19 |
| 2012 | $-12 |
| 2011 | $-3 |
| Aratana Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2019-03-31 | $-7 |
| 2018-12-31 | $-7 |
| 2018-09-30 | $10 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-15 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-9 |
| 2017-03-31 | $-11 |
| 2016-12-31 | $-23 |
| 2016-09-30 | $-12 |
| 2016-06-30 | $22 |
| 2016-03-31 | $-17 |
| 2015-12-31 | $-12 |
| 2015-09-30 | $-54 |
| 2015-06-30 | $-11 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-12 |
| 2014-09-30 | $-10 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-9 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-5 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-3 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-3 |
